CDIO vs. SAI, MLGO, ARIZ, MCAG, VNRX, ABIO, ICCC, AWH, OCX, and TRIB
Should you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include SAI.TECH Global (SAI), MicroAlgo (MLGO), Arisz Acquisition (ARIZ), Mountain Crest Acquisition Corp. V (MCAG), VolitionRx (VNRX), ARCA biopharma (ABIO), ImmuCell (ICCC), Aspira Women's Health (AWH), OncoCyte (OCX), and Trinity Biotech (TRIB).
SAI.TECH Global (NASDAQ:SAI) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking.
Cardio Diagnostics received 3 more outperform votes than SAI.TECH Global when rated by MarketBeat users.
In the previous week, Cardio Diagnostics had 2 more articles in the media than SAI.TECH Global. MarketBeat recorded 2 mentions for Cardio Diagnostics and 0 mentions for SAI.TECH Global. SAI.TECH Global's average media sentiment score of 0.86 beat Cardio Diagnostics' score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the news media.
SAI.TECH Global has a beta of 1.86, meaning that its stock price is 86% more volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 5.12, meaning that its stock price is 412% more volatile than the S&P 500.
0.2% of SAI.TECH Global shares are held by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are held by institutional investors. 30.0% of Cardio Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
SAI.TECH Global has higher revenue and earnings than Cardio Diagnostics.
Cardio Diagnostics has a consensus target price of $2.00, suggesting a potential upside of 195.25%. Given SAI.TECH Global's higher possible upside, analysts clearly believe Cardio Diagnostics is more favorable than SAI.TECH Global.
SAI.TECH Global has a net margin of 0.00% compared to SAI.TECH Global's net margin of -34,911.87%. Cardio Diagnostics' return on equity of 0.00% beat SAI.TECH Global's return on equity.
Summary
Cardio Diagnostics beats SAI.TECH Global on 9 of the 14 factors compared between the two stocks.
Get Cardio Diagnostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardio Diagnostics Competitors List
Related Companies and Tools
